Vir Biotechnology Inc. (VIR) and GlaxoSmithKline's (GSK) Sotrovimab Retains Activity Against Key Omicron Mutations, per Preclinical Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. META
4. DPZ
5. IBM
6. CNC
7. KFY
8. SPY
9. MU
10. ENRD

Go back to Vir Biotechnology Inc. (VIR) and GlaxoSmithKline's (GSK) Sotrovimab Retains Activity Against Key Omicron Mutations, per Preclinical Data
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 50.74 --0 (-0%)
Previous Close $50.74    52 Week High $45.58 
Open $50.74    52 Week Low $37.82 
Day High $50.74    P/E N/A 
Day Low $50.74    EPS $0.00 
Volume 10,437       

(NASDAQ: VIR) Delayed: 9.57 --0 (-0%)
Previous Close $9.57    52 Week High $ 
Open $9.57    52 Week Low $ 
Day High $9.57    P/E N/A 
Day Low $9.57    EPS $ 
Volume 697